Telehealth as effective as personal contact
Results from an American study of more than 2,200 people with Type 1 diabetes and their caregivers, showed a majority of those who opted for
Results from an American study of more than 2,200 people with Type 1 diabetes and their caregivers, showed a majority of those who opted for
The 24-week results from a trial, DEPICT-1, people with Type 1 diabetes taking the oral selective SGLT-2 inhibitor class of diabetes medicines show that dapagliflozin,